SUMMIT, N.J.--(BUSINESS WIRE)--
Celgene Corporation (CELG) will host a conference call and live audio webcast on Thursday, July 28, 2016 at 9 a.m. ET to discuss second quarter 2016 financial and operational results. The webcast can be accessed from the Investor Relations page at www.celgene.com.
About Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. For more information, please visit www.celgene.com. Follow Celgene on Social Media: @Celgene, Pinterest, LinkedIn, FaceBook and YouTube.
